KinDex Therapeutics
Manufacturing · Washington, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9770 44th Ave, Gig Harbor, Washington, 9...Phone Number
(206) 447-1455Website
www.kindexus.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About KinDex Therapeutics
KinDex Pharmaceuticals is dedicated to the discovery and development of therapeutics aimed at improving women's health and addressing chronic diseases. The company focuses on molecules that interact with Bitter Taste Receptors (TAS2Rs) to target inflammation and metabolic dysfunction, particularly in conditions like Polycystic Ovary Syndrome (PCOS), obesity, and diabetes. Their lead candidate, KDT501, is an orally dosed small molecule that has shown safety and efficacy in clinical trials and is set to be studied further in PCOS patients. KinDex primarily serves women of reproductive age who are affected by endocrine disorders and related health issues.Explore more
KinDex Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KinDex Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once KinDex Therapeutics has new funding data
KinDex Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if KinDex Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on KinDex Therapeutics recently announced quarterly report
Click to see if KinDex Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when KinDex Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if KinDex Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at KinDex Therapeutics
Recommended Actions
Reach out to Masked Content who joined KinDex Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to KinDex Therapeutics
Compare insights from companies similar to KinDex Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
KinDex Therapeutics
<$5M
1-10
Private
-
2009
LB
Lincoln BouillonChief Financial Officer & Corporate Secretary & Treasurer
Company Profile Activity
Activity Insights
KinDex Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
KinDex Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about KinDex Therapeutics.
KinDex Therapeutics Tech Stack
A closer look at the technologies used by KinDex Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KinDex Therapeutics
Sign Up For FreeTo access detailed company insights
KinDex Pharmaceuticals is dedicated to the discovery and development of therapeutics aimed at improving women's health and addressing chronic diseases. The company focuses on molecules that interact with Bitter Taste Receptors (TAS2Rs) to target inflammation and metabolic dysfunction, particularly in conditions like Polycystic Ovary Syndrome (PCOS)... Read More
